Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0002034056-25-000009

General Counsel sold 1,304 shares at an average $367.81 ($479,627)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kelley Shannon T · General Counsel

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-18 Sale : show line 1 in the form 10b5-1 −458 $358.66 $164,266 10,019 D
2025-08-18 Sale : show line 2 in the form 10b5-1 −126 $369.64 $46,575 9,893 D
2025-08-18 Sale : show line 3 in the form 10b5-1 −84 $370.06 $31,085 9,809 D
2025-08-18 Sale : show line 4 in the form 10b5-1 −84 $371.35 $31,193 9,725 D
2025-08-18 Sale : show line 5 in the form 10b5-1 −252 $372.44 $93,855 9,473 D
2025-08-18 Sale : show line 6 in the form 10b5-1 −68 $374.13 $25,441 9,405 D
2025-08-18 Sale : show line 7 in the form 10b5-1 −190 $375.75 $71,393 9,215 D
2025-08-18 Sale : show line 8 in the form 10b5-1 −42 $376.62 $15,818 9,173 D
Open-market sales · 1,304 sh · avg $367.81 · $479,627
Loading xslF345X05/wk-form4_1755552828.xml…